On 2026-08-12, Kairos Pharma, Ltd. (KAPA) announced earnings per share of $-0.42 for the fiscal quarter ending 2026-06-30, beating the average analyst estimate of $-0.63.
The next expected annoucement date for quarterly earnings is 2026-11-13, with an average estimated earnings per share of $-0.63 for the fiscal quarter ending 2026-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-08-12 | 2026-06-30 | $-0.63 | $-0.42 |
| 2026-05-13 | 2026-03-31 | $-0.49 | $-0.56 |
| 2026-03-31 | 2025-12-31 | -- | $-0.49 |
| 2025-11-14 | 2025-09-30 | $-0.70 | $-0.49 |
| 2025-08-12 | 2025-06-30 | $-0.42 | $-0.56 |
| 2025-05-14 | 2025-03-31 | $-0.35 | $-0.56 |
| 2025-04-15 | 2024-12-31 | -- | $-0.56 |
| 2024-11-14 | 2024-09-30 | -- | $-0.70 |